Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Best Practice With Rocuronium, Neostigmine, Sugammadex, and Subjective Monitoring.

NCT03543826 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT03543826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03543826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Best Practice With Rocuronium, Neostigmine, Sugammadex, and Subjective Monitoring.
Lead sponsor
University of Washington
Phase
Phase 4
Overall status
Completed
Start date
May 21, 2018
Completion date
November 26, 2018
Enrollment
201 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

muscle weakness